COMPLETED

Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.

Official Title

Impact of Dietary Sodium Supplementation on Growth & Intestinal Microbiome in Preterm Infants

Quick Facts

Study Start:2023-02-08

Study Completion:2025-04-14

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT05546814

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Weeks to 30 Weeks

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Birthweight \>500 grams and * Gestational age at least 25 0/7weeks but less than 30 weeks. * \<14 days of age at time of randomization	* Non-English speaking parents * Major congenital anomalies * grade underlying renal dysfunction (serum creatinine \> 1.0 mg/dL or increase of \>0.3 mg/DL between any two consecutive measurements) * use of diuretics at the time initiation of intervention (approximately 14 days of age) But this is not completely an exclusion-the research can wait 2 days and at the time of 2 week time period of the study we can re check their levels * any structural genitourinary criteria.

Inclusion Criteria

Exclusion Criteria

* Birthweight \>500 grams and
* Gestational age at least 25 0/7weeks but less than 30 weeks.
* \<14 days of age at time of randomization

* Non-English speaking parents
* Major congenital anomalies
* grade underlying renal dysfunction (serum creatinine \> 1.0 mg/dL or increase of \>0.3 mg/DL between any two consecutive measurements)
* use of diuretics at the time initiation of intervention (approximately 14 days of age) But this is not completely an exclusion-the research can wait 2 days and at the time of 2 week time period of the study we can re check their levels
* any structural genitourinary criteria.

Contacts and Locations

Principal Investigator

Jeffrey Segar, MD

PRINCIPAL_INVESTIGATOR

Medical College of Wisconsin

Study Locations (Sites)

Children's wisconsin

Milwaukee, Wisconsin, 53226

United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

Jeffrey Segar, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-08

Study Completion Date2025-04-14

Study Record Updates

Study Start Date2023-02-08

Study Completion Date2025-04-14

Terms related to this study

Additional Relevant MeSH Terms

Preterm Birth